Anemia is a risk factor for cardiovascular disease, but its impact on new-onset atrial fibrillation (AF) is unclear. In this study, we investigated the effect of hemoglobin (Hb) levels and their changes on the risk of Af development in the general population of Korea. We retrospectively analyzed a cohort from the Korean National Health Insurance Service database and identified 9,686,314 subjects (49.8% male) without a history of AF, aged ≥40 years, and with Hb levels available for both first (2009-2010) and second (2011-2012) health checkups. These subjects were followed up until 2017 to determine AF development. The presence of anemia (Hb level <13 g/dL in men and <12 g/dL in women) was a significant risk factor for AF development. However, Hb levels showed a U-shaped association with incident AF after adjustment for cardiovascular risk factors. AF incidence was lowest at Hb levels of 14-14.9 g/dL in men and 12-12.9 g/dL in women. Among individuals with Hb levels within normal ranges (13-15.9 g/dL in men and 12-14.9 g/dL in women), both decrease and increase in Hb levels at the second measurement outside the normal ranges showed an elevation of AF risk by 11% and 21% for men and 3% and 36% for women, respectively, compared with those who maintained normal Hb levels. in conclusion, low or high Hb levels are associated with an increased risk of incident Af. this study suggests that maintaining Hb levels within the normal ranges confers a low risk of Af development.Atrial fibrillation (AF) increased the risk of ischemic stroke and death 1,2 . As the population ages, the prevalence of AF increases, which has a significant impact on public health 3,4 . Therefore, it is important to establish a simple health screening method that can identify people at high risk of AF development.Anemia is associated with an increased risk of cardiovascular morbidity and mortality in patients with chronic kidney disease, heart failure, or coronary artery disease 5 . In the general population, anemia is also a risk factor for cardiovascular diseases 6 . Several studies suggest that high hematocrit or hemoglobin (Hb) levels are also associated with cardiovascular outcomes 7-9 . However, the impact of anemia or Hb level on AF development in the general population has not been well understood. In this study, we aimed to investigate the effect of Hb levels and their changes on the risk of AF development in the general population of Korea. (index year). Among them, we excluded 3,192,730 subjects who were less than 40 years of age, were diagnosed with AF or mitral stenosis, have mechanical heart valves, and whose Hb levels were unavailable, or <5 or ≥20 g/dL. Finally, 9,686,314 individuals were included and followed up until 2017. Figure 1 and Supplementary Figure 1 show the detailed study flow.We obtained baseline characteristics of study subjects, including age, sex, body mass index, and comorbidities such as hypertension, diabetes, dyslipidemia, ischemic heart disease, congestive heart failure, stroke, chronic obstructive pulmonary diseas...